Donepezil and Memantine-Induced Second-Degree Atrioventricular Block: A Case Report

Overview

Journal Hosp Pharm

Publisher Sage Publications

Date 2024 Nov 15

PMID 39544830

Authors

Manjappa Mahadevappa

Sakeer Hussain

Shivananda Manohar

Affiliations

Soon will be listed here.

Abstract

Donepezil and memantine are second-generation antipsychotics widely used in the management of mild to moderate Alzheimer's disease. These drugs are highly selective for the central nervous system, targeting different neural pathways to mitigate cognitive decline. Donepezil is a reversible and specific acetylcholinesterase inhibitor, while memantine is an NMDA receptor antagonist which modulates glutamatergic activity. Although these medications are safe, they are associated with adverse effects, and cardiovascular complications are rare. The reported cardiac adverse drug reactions include bradycardia, atrioventricular block, and prolonged QT interval. We are reporting a case of an 81-year-old male patient with schizophrenia, Alzheimer's disease and bilateral sensorineural deafness receiving oral donepezil and memantine presented with second-degree atrioventricular block. The patient's atrioventricular block recovered completely in 2 to 3 weeks after the discontinuation of donepezil-memantine and with a short course of sympathomimetic drugs.

References

Asiri Y, Mostafa G . Donepezil. Profiles Drug Subst Excip Relat Methodol. 2012; 35:117-50. DOI: 10.1016/S1871-5125(10)35003-5. View

Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30(2):239-45. DOI: 10.1038/clpt.1981.154. View

Alonge O, Iqbal F, Cifonelli E . Collapse in the elderly: rivastigmine-induced heart block and a literature review of the pharmacology of acetylcholinesterase inhibitors used in Alzheimer's disease. BMJ Case Rep. 2018; 2018. PMC: 5905772. DOI: 10.1136/bcr-2018-224597. View

Mirza M, Strunets A, Shen W, Jahangir A . Mechanisms of arrhythmias and conduction disorders in older adults. Clin Geriatr Med. 2012; 28(4):555-73. PMC: 3610528. DOI: 10.1016/j.cger.2012.08.005. View

Suleyman T, Tevfik P, Abdulkadir G, Ozlem S . Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil. Emerg Med J. 2006; 23(8):641-2. PMC: 2564171. DOI: 10.1136/emj.2006.036251. View

Narula O, Scherlag B, Javier R, HILDNER F, SAMET P . Analysis of the A-V conduction defect in complete heart block utilizing His bundle electrograms. Circulation. 1970; 41(3):437-48. DOI: 10.1161/01.cir.41.3.437. View

Odenigbo N, Nkemjika S, Atolagbe A, Nwabueze C, Olwit C, Lawrence J . Donepezil-induced bradycardia in a schizophrenic patient with comorbid neurocognitive disorder: a case report and review of the literature. J Med Case Rep. 2024; 18(1):129. PMC: 10967060. DOI: 10.1186/s13256-024-04454-x. View

Hartwig S, Siegel J, SCHNEIDER P . Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992; 49(9):2229-32. View

Howes L . Cardiovascular effects of drugs used to treat Alzheimer's disease. Drug Saf. 2014; 37(6):391-5. DOI: 10.1007/s40264-014-0161-z. View

10.

Dunn N, Pearce G, Shakir S . Adverse effects associated with the use of donepezil in general practice in England. J Psychopharmacol. 2001; 14(4):406-8. DOI: 10.1177/026988110001400410. View

11.

Tanaka A, Koga S, Hiramatsu Y . Donepezil-induced adverse side effects of cardiac rhythm: 2 cases report of atrioventricular block and Torsade de Pointes. Intern Med. 2009; 48(14):1219-23. DOI: 10.2169/internalmedicine.48.2181. View

12.

Bordier P, Lanusse S, Garrigue S, Reynard C, Robert F, Gencel L . Causes of syncope in patients with Alzheimer's disease treated with donepezil. Drugs Aging. 2005; 22(8):687-94. DOI: 10.2165/00002512-200522080-00005. View

13.

Schumock G, Thornton J . Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992; 27(6):538. View

14.

Kusumoto F, Schoenfeld M, Barrett C, Edgerton J, Ellenbogen K, Gold M . 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice.... Circulation. 2018; 140(8):e333-e381. DOI: 10.1161/CIR.0000000000000627. View

15.

Osmonov D, Ozcan K, Erdinler I, Altay S, Turkkan C, Yildirim E . Anticholinesterase-induced symptoms improved by pacemaker implantation in patients with Alzheimer's disease: analysis of 6 cases. Am J Alzheimers Dis Other Demen. 2012; 27(5):311-4. PMC: 10845648. DOI: 10.1177/1533317512452040. View